|
Our goal is to be a leader in neuroscience research delivering a range of life-changing medicines in key areas of unmet medical need. We are making great research efforts in diseases related to the central nervous system (CNS). Our research in this field is focused on neurological diseases, psychiatric disorders, and pain and anaesthesia. Areas of Interest Decrease of amyloid beta - Biopharmaceutical Aß approach - BACE inhibitor - RAGE inhibitor - Gamma secretase modulator Inhibitors of tau phosphorylation Symptomatic treatment agents superior to AChE inhibitors |
